panitumumab

CHEBI:CHEBI_754099

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
panitumumab
rxcui
1657723
pharm_class
HER1 Antagonists [MoA]
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
SOLUTION
route
INTRAVENOUS
marketing_category
BLA
active_ingredient_strength
100 mg/5mL
nui
N0000020010
pharm_class_cs
Antibodies, Monoclonal [CS]
labeler_name
Amgen Inc
manufacturer_name
Amgen Inc
pharm_class_epc
Epidermal Growth Factor Receptor Antagonist [EPC]
pharm_class_moa
HER1 Antagonists [MoA]
marketing_start_date
20061010
package_marketing_start_date
20061010
brand_name
Vectibix
brand_name_base
Vectibix
product_ndc
55513-954
application_number
BLA125147
spl_id
59928d12-bde9-4433-8316-a142514ef952
active_ingredient_name
PANITUMUMAB
package_ndc
55513-954-01
package_description
1 VIAL, SINGLE-DOSE in 1 CARTON (55513-954-01) / 5 mL in 1 VIAL, SINGLE-DOSE
unii
6A901E312A
spl_set_id
e0fa4bca-f245-4d92-ae29-b0c630a315c2
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class